Tech Company Financing Transactions
Promaxo Funding Round
Promaxo closed a $100 million Series C funding round on 10/22/2026. Backers included Amara Ventures, New Science Ventures and private investors.
Transaction Overview
Company Name
Announced On
10/22/2026
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$100,000,000
Round
Series C
Investors
New Science Ventures (Somu Subramaniam)
Proceeds Purpose
The new capital will support expanded manufacturing capacity, backlog reduction, and new regulatory filings.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
70 Washington St. 407
Oakland, CA 94607
USA
Oakland, CA 94607
USA
Phone
Website
Email Address
Overview
Promaxo's patented MR technology takes advantage of proprietary ultra-fast and strong gradients and pre-polarization fields which can be switched on rapidly without causing bio-effects (e.g., nerve stimulation). Our prototype MRI systems have demonstrated rise- and fall-times about one-hundred times faster than conventional MRI.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amit Vohra
Chief Operating Officer
Dinesh Kumar
Chief Technical Officer
Aleksandar Nacev
VP - Bus. Development
Michael Bartholomew
VP - Product Management
Ram Narayanan
Browse more venture capital transactions:
Prev: 10/22/2026: Sustainable Bioproduct Innovations venture capital transaction
Next: 10/23/2026: Maxinsights venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs